L is for Lab Automation
Posted: 29 November 2016 | | No comments yet
L is for Lab Automation – the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research…
With just over a month left until the end of year, we decided to bring together the biggest and best pharmaceutical news from over the last 12 months to make sure you’re up to date when it comes to our ever growing industry. An opportunity to look at how far we’ve come in our fight against the world’s deadliest and most widespread diseases, and how very far we still have to go in finding new drug targets and treatments against many more. From Antibiotics to Zika, drug discovery to regulatory approval, new treatments, better medicines, healthcare cuts and novel approaches – all to find solutions to the many unmet calls for aid seen around the globe, let European Pharmaceutical Review put you in the know.
L is for Lab Automation
Demands in medical automation technology brings two prominent players close. Trajan has been in the news over the past few months. The company brought all speculations to rest when it announced its decision to invest in LEAP Technologies Inc.
Continuous processing will require a change in mindset for controls and automation
Check back tomorrow for the next letter in our pharma alphabet!
What do you think? We’d love to hear from you so drop us a comment below and tell us your thoughts.
CALL FOR WRITERS
Is this your specialist subject? Are you a scientist, student or do you work in the pharmaceutical industry? If you’d like contribute an article to the website and/or become one of our expert writers, please do get in touch with Niamh Marriott